Literature DB >> 19868940

THE BLOOD PLATELETS IN PNEUMOCOCCUS INFECTIONS.

H A Reimann1.   

Abstract

1. A study was made of the behavior of the blood platelets during the course of pneumonia in man, as also in several rabbits experimentally infected with pneumococci. 2. The number of platelets begins to diminish after the infection has become established. A thrombopenia occurs during the febrile period. Immediately following the onset of the crisis in lobar pneumonia or after the temperature begins to fall by lysis, the platelets begin gradually to increase in number. In the postfebrile period, the platelet count increases until the normal number is greatly exceeded, and there is a return to the normal number only after about 2 weeks. 3. Sequelae, characterized by fever, following pneumonia are accompanied by a renewed diminution in the number of platelets. After subsidence of the temperature their number usually increases until the normal is again exceeded. 4. The platelets in general are smaller and contain more granules during the thrombopenic stage of pneumonia. 5. Intravenous injection of antipneumococcus serum during pneumonia ordinarily produces no variation in the number of platelets.

Entities:  

Year:  1924        PMID: 19868940      PMCID: PMC2128590          DOI: 10.1084/jem.40.4.553

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  1 in total

1.  COAGULATION TIME OF THE BLOOD IN LOBAR PNEUMONIA.

Authors:  A R Dochez
Journal:  J Exp Med       Date:  1912-11-01       Impact factor: 14.307

  1 in total
  2 in total

Review 1.  Infectious diseases. Annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1965-09       Impact factor: 2.401

2.  Development of a novel preclinical model of pneumococcal pneumonia in nonhuman primates.

Authors:  Bryan D Kraft; Claude A Piantadosi; Ashlee M Benjamin; Joseph E Lucas; Aimee K Zaas; Marisol Betancourt-Quiroz; Christopher W Woods; Alan L Chang; Victor L Roggli; Craig D Marshall; Geoffrey S Ginsburg; Karen Welty-Wolf
Journal:  Am J Respir Cell Mol Biol       Date:  2014-05       Impact factor: 6.914

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.